Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Citi
Express Scripts
AstraZeneca
Colorcon
Accenture
US Department of Justice
UBS
Healthtrust
Merck

Generated: January 20, 2018

DrugPatentWatch Database Preview

PHENTERMINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Phentermine Hydrochloride patents expire, and when can generic versions of Phentermine Hydrochloride launch?

Phentermine Hydrochloride is a drug marketed by Abc Holding, Able, Aurolife Pharma Llc, Barr, Camall, Chartwell Rx, Duramed Pharms Barr, Elite Labs, Elite Labs Inc, Invagen Pharms, Ivax Pharms, Ken Lifescience, Kvk Tech, Lannett, Lannett Holdings Inc, Mikah Pharma, Sandoz, Sun Pharm Industries, Teva, Tg United Inc, Upsher-smith Labs, Usl Pharma, Vitarine, Watson Labs, Zydus Pharms Usa Inc, Actavis Elizabeth, Ingenus Pharms Nj, Kvk Tech Inc, Polygen Pharms, Prinston Inc, Sandoz Inc, and Sun Pharm Inds Inc. and is included in eighty-seven NDAs.

The generic ingredient in PHENTERMINE HYDROCHLORIDE is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.

US Patents and Regulatory Information for PHENTERMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET;ORAL 083923-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lannett PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 091359-001 Jul 16, 2010 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ken Lifescience PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 205019-001 Dec 5, 2014 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Prinston Inc PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET;ORAL 040377-001 Jan 4, 2002 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 088414-001 Oct 19, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher-smith Labs PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 088430-001 Mar 27, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 086945-001 Jul 20, 1983 AA RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 040525-001 Oct 23, 2003 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 088612-001 Apr 4, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vitarine PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET;ORAL 086453-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Dow
Accenture
Healthtrust
McKesson
Colorcon
Mallinckrodt
Medtronic
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot